Ultragenyx Pharmaceutical Inc.
RARE
Revenue
166.50M
▲27.20M▲19.53%
3 Months ChangeAssets
1.31B
▼-5.66M▼-0.4316%
3 Months ChangeLiabilities
1.15B
▼-12.70M▼-1.09%
3 Months ChangeFree Cash Flow
-167.80M
▲26.14M▲13.48%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-07
Form 8-K
ID: 0000950170-24-113085
2024-10-03
Form 8-K
ID: 0000950170-24-112402
2024-08-02
Form 10-Q
ID: 0000950170-24-089488
2024-08-01
Form 8-K
ID: 0000950170-24-089263
2024-07-17
Form 8-K
ID: 0000950170-24-084254
2024-06-21
Form 8-K
ID: 0000950170-24-076222
2024-06-17
Form 8-K
ID: 0001193125-24-162003
2024-06-12
Form 8-K
ID: 0000950170-24-072414
2024-06-12
Form 8-K
ID: 0000950170-24-072119
2024-05-30
Form 8-K
ID: 0000950170-24-066553